ACB.TO · Aurora Cannabis Inc

-

Please sign in to comment on ACB.TO

1 Comment

Admin

4 years, 3 months ago

Aurora Cannabis Inc is currently in a long term downtrend where the price is trading 8.9% below its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.

Aurora Cannabis Inc's total revenue rose by 20.8% to $68M since the same quarter in the previous year.

Its net income has increased by 77.2% to $-293M since the same quarter in the previous year.

Finally, its free cash flow grew by 70.3% to $-78M since the same quarter in the previous year.

Based on the above factors, Aurora Cannabis Inc gets an overall score of 4/5.

ISIN	CA05156X8504
Exchange	TO
CurrencyCode	CAD
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Beta	3.32
PE Ratio	20.9
Target Price	9.24
Market Cap	353M
Dividend Yield	None

ABOUT

Aurora Cannabis Inc

Aurora Cannabis Inc., together with its subsidiaries, engages in production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; sale of medical and consumer use cannabis products; and the propagation of vegetables and floral plants. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

ACB.TO · Aurora Cannabis Inc

-

Aurora Cannabis Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Aurora Cannabis Inc using a moving average strategy